Loading…
Bal Pharma (BALPHARMA)₹83.18+0.80%Pharmaceuticals
At the end of the Jun 2026 quarter, Bal Pharma's shareholders were: promoters 50.83%, FIIs 0.15%, public 49.02%. Promoter holding is unchanged on the quarter. It had 14,969 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 51.57% | 51.20% | 51.20% | 51.20% | 50.83% | 50.83% | 50.83% | 50.83% | 50.83% | 50.83% | 50.83% | 50.83% |
| FIIs | 0.14% | 0.13% | 0.13% | 0.13% | 0.13% | 0.14% | 0.14% | 0.15% | 0.23% | 0.14% | 0.14% | 0.15% |
| Public | 48.29% | 48.67% | 48.67% | 48.67% | 49.04% | 49.03% | 49.03% | 49.02% | 48.94% | 49.03% | 49.03% | 49.02% |
| Number of shareholders | 15,524 | 15,055 | 14,767 | 15,009 | 16,002 | 15,662 | 15,718 | 15,821 | 15,769 | 15,515 | 15,209 | 14,969 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Shailesh Siroya | Promoter | 17.28% | 0.00 |
| Micro Labs Limited | Promoter | 12.66% | New |
| Anita Siroya | Promoter | 6.63% | 0.00 |
| Prakash Chandra Jain | Public | 3.42% | −0.21 |
| Ram Keshav Murthy | Public | 3.34% | 0.00 |
| Anand Surana | Promoter | 3.33% | 0.00 |
| Chandraprakash Dheerajmal Siroya | Promoter | 3.05% | 0.00 |
| Dilip Surana | Promoter | 3.00% | 0.00 |
| Shreya Mardia | Public | 1.89% | 0.00 |
| Naresh D P | Public | 1.86% | −0.01 |
| Asha Tapidas Dodhia | Public | 1.86% | 0.00 |
| Archana Surana | Promoter | 1.80% | 0.00 |
| Gautam Chand Mehta | Public | 1.15% | −0.03 |
| Monica Surana | Promoter | 1.12% | 0.00 |
| Dilip Surana (Huf) | Promoter | 1.06% | 0.00 |
| Anita Chandraprakash Siroya | Promoter | 0.77% | 0.00 |
| Jivi Dheerajmal Siroya | Promoter | 0.29% | 0.00 |
| Micro Labs | Promoter | Exited | — |
Promoters held 50.83% of Bal Pharma at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.15% (up 0.01 percentage points from 0.14% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Bal Pharma had 14,969 shareholders at the end of the Jun 2026 quarter, against 15,821 a year earlier.
Prakash Chandra Jain (Public) held 3.42% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.